Mesalamine
Product manufactured by Avkare, Inc
Indications and Purposes
| 1 Indications And Usage Mesalamine Delayed-Release Tablets Are Indicated For The Induction Of Remission In Patients With Active, Mild To Moderate Ulcerative Colitis And For The Maintenance Of Remission Of Ulcerative Colitis. Mesalamine Delayed-Release Tablets Are A Locally Acting 5-Aminosalicylic Acid (5-Asa) Indicated For The Induction Of Remission In Adults With Active, Mild To Moderate Ulcerative Colitis And For The Maintenance Of Remission Of Ulcerative Colitis. ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Mesalamine |
|
ZINC1688 |